NHF’s QMS is ISO 9001:2015 Certified

Government of Jamaica

MORE DRUGS FOR NHFCARD BENEFICIARIES

MORE DRUGS FOR NHFCARD BENEFICIARIES

Five new active pharmaceutical ingredients have been added to the National Health Fund (NHF) Drug list for the benefit of persons covered on its Individual Benefits Programme for Hypertension, Vascular and Ischaemic Heart Disease.

Tromblatt-AS Tablets, a combination of clopidogrel and aspirin will benefit persons suffering with ischaemic heart disease and vascular disease. Tromlatt-AS is subsidized at $46.03 per tablet.

Coveram Tablets, a combination of perindopril and amlodipine and Calchek-A Tablets, a combination of amlodipine and atenolol were both added for the treatment of hypertension and ischaemic heart disease. NHF provides subsidies for the many presentations of Coveram Tablets, for example the subsidy for Coveram 5mg/5mg is $47.65 per tablet. In addition the subsidy for Calchek-A is $13.56 per tablet.

Exforge, a combination of amlodipine and valsartan, as well as Exforge HCT , a combination of amlodipine, valsartan and hydrochlorothiazide were also added for the treatment of hypertension. NHF provides subsidies for the many presentations of these drugs . For example the subsidy for Exforge 5mg/80mg is $36.05 per tablet, while the subsidy for Exforge HCT 5mg/160mg/12.5mg is $64.28 per tablet.

Details of the NHF subsidies for these and other items are available on the NHF website at www.nhf.org.jm ; the NHF Individual Benefits Booklet which is available at NHF Provider pharmacies or by calling the NHF offices.

For further information contact: Rosemarie Lee, Tel.906-1106

National Health Fund © 2024. All Rights Reserved.